A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

New FDA-Approved HeartLight X3 System for Cardiac Ablations Is Available at Delray Medical Center: First in Palm Beach County, Florida

HeartLight X3 Endoscopic Ablation System Offers Symptom Relief for South Florida Area Patients

What To Know

  • While older treatments rely on x-ray or mapping support for guidance, the X3 System's innovative HeartLight catheter is equipped with a miniature video camera and “headlight” to deliver a direct, live-action view of the inside of the heart.
  •   It is very rewarding to be able to continue to bring some of the latest medical innovations to our area, and we remain on the forefront of the latest cardiac treatment options.

Delray Medical Center, part of the Palm Beach Health Network, is the first hospital in Palm Beach County to offer patients The HeartLight X3 System for cardiac ablations.  This procedure offers some of the most advanced treatments for patients with atrial fibrillation, the most common heart rhythm disorder.  Interventional cardiologist Dr. Mark Freher is the first surgeon to perform the procedure in our area using the system’s miniaturized camera and advanced laser technology.

“At Delray Medical Center, we are committed to innovation and offering patients early access to many of the latest cardiac treatment advancements, including devices like the HeartLight X3 System,” said Dr. Mark Freher, electrophysiologist on staff at Delray Medical Center. “We have taken the necessary steps to perform surgical procedures in a safe and secure environment, and our community can rest assured that we have the appropriate supplies and protocols in place.”

The HeartLight X3 Endoscopic Ablation System, developed by CardioFocus Inc.,  is designed for physicians to perform pulmonary vein isolation (PVI) procedures with accuracy, precision, and confidence. The PVI procedure creates areas of scar tissue around the pulmonary veins to block the electrical signals that cause arrhythmia. While older treatments rely on x-ray or mapping support for guidance, the X3 System’s innovative HeartLight catheter is equipped with a miniature video camera and “headlight” to deliver a direct, live-action view of the inside of the heart. The system also enables the physician to customize the amount of laser energy used during the procedure based upon the patient’s specific needs, and HeartLight’s unique balloon design adapts to the heart’s specific anatomy.

“I want to congratulate Dr. Freher and our cardiac team on becoming the first in Palm Beach County to perform this advanced procedure,” said Maggie Gill, chief executive officer of the Palm Beach Health Network and Delray Medical Center.  It is very rewarding to be able to continue to bring some of the latest medical innovations to our area, and we remain on the forefront of the latest cardiac treatment options.”

AFib is a serious condition that causes a quick, often chaotic heartbeat. Left untreated it can lead to weakness, breathlessness, fainting and a decreased quality of life. In addition, AFib patients face an increased risk of stroke, which is the fifth leading cause of death in the state of Florida. With proper treatment, patients affected by this debilitating condition can get safe symptom relief.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy